Hu Kai-wen, Li Quan-wang, Zuo Ming-huan, Sun Tao, Jiang Min
Tumor Department, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078, China.
Chin J Integr Med. 2007 Sep;13(3):224-7. doi: 10.1007/s11655-007-0224-4.
To observe the clinical effect of the combined therapy using argon-helium cryosurgery (Ar-He knife) and Chinese herbal medicine in treating non-small cell lung cancer (NSCLC).
Fifty-seven patients of NSCLC were treated with the combined therapy and observed.
The treatment was successfully completed in all patients with mild adverse reactions. The effective rate was 83.8% 3 months after the operation, 79.6% 6 months after the operation, and 77.3% 12 months after the operation, with median survival of 9 months. The survival rate after 12 months was 46.67% (21/45), 34.62% (9/26) after 18 months, and 36.36% (4/11) after 24 months.
Argon-helium cryosurgery therapy is superior in its assured orientation, quick tumor load deprivation and less postoperational reaction. Combined with Chinese herbal medication, Argon-helium cryosurgery therapy can prolong survival time, relieve clinical symptoms, and elevate the quality of life in NSCLC patients, and is thus worthy of promotion.
观察氩氦刀冷冻手术联合中药治疗非小细胞肺癌（NSCLC）的临床疗效。
对57例NSCLC患者采用联合疗法进行治疗并观察。
所有患者均顺利完成治疗，不良反应轻微。术后3个月有效率为83.8%，术后6个月为79.6%，术后12个月为77.3%，中位生存期为9个月。12个月生存率为46.67%（21/45），18个月为34.62%（9/26），24个月为36.36%（4/11）。
氩氦刀冷冻手术治疗定位准确、能快速减轻肿瘤负荷且术后反应较小。联合中药治疗可延长NSCLC患者的生存时间，缓解临床症状，提高生活质量，值得推广。
